Spc Financial, Inc. Astrazeneca PLC Transaction History

Spc Financial, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$69.91 - $75.81 $41,946 - $45,486	-600 Reduced 14.63%	3,500 $250,000
Q1 2023 May 09, 2023	SELL	$63.15 - $71.6 $25,260 - $28,639	-400 Reduced 8.89%	4,100 $284,000
Q4 2022 Jan 31, 2023	SELL	$54.21 - $70.44 $32,526 - $42,264	-600 Reduced 11.76%	4,500 $305,000
Q3 2022 Oct 26, 2022	SELL	$53.02 - $135.75 $42,416 - $108,600	-800 Reduced 13.56%	5,100 $280,000
Q2 2022 Aug 03, 2022	SELL	$59.26 - $71.14 $35,556 - $42,684	-600 Reduced 9.23%	5,900 $390,000
Q1 2022 May 02, 2022	SELL	$55.72 - $67.12 $33,432 - $40,272	-600 Reduced 8.45%	6,500 $431,000
Q4 2021 Jan 31, 2022	SELL	$54.02 - $63.83 $32,412 - $38,298	-600 Reduced 7.79%	7,100 $414,000
Q3 2021 Nov 05, 2021	BUY	$55.56 - $60.79 $427,812 - $468,083	7,700 New	7,700 $462,000

1,336

477M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $220B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Spc Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Spc Financial, Inc. with notifications on news.